, Volume 7, Issue 1, pp 40–61 | Cite as

Lo screening delle malattie genetiche del surrene

  • Francesca Pecori Giraldi


L’analisi genetica sta assumendo un’importanza crescente nell’ambito della patologia surrenalica sia per l’identificazione dei geni responsabili di sindromi note da tempo, ad esempio del morbo di von Hippel-Lindau, sia per il riconoscimento di nuove entità cliniche trasmesse in maniera ereditaria, ad esempio il complesso di Carney. Questo articolo si propone di passare in rassegna le patologie surrenaliche in cui è stata identificata una base genetica e illustrare le metodiche di analisi genetica più appropriate.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci 1038: 14, 2004.PubMedCrossRefGoogle Scholar
  2. 2.
    Yanase T. 17 alpha-hydroxylase/17, 20-lyase defects. J Steroid Biochem Mol Biol 53: 153, 1995.PubMedCrossRefGoogle Scholar
  3. 3.
    Arlt W, Walker EA, Draper N, Ivosin HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM. Congenital adrenal hyperplasia caused by mutant P450 oxireductase and human androgen synthesis: an analytical study. Lancet 363: 2128, 2004.PubMedCrossRefGoogle Scholar
  4. 4.
    White PC, Curnow KM, Pascoe L. Disorders of steroid 1 1β-hydroxylase isoenzymes. Endocr Rev 15: 421, 1994.PubMedGoogle Scholar
  5. 5.
    White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol 217: 81, 2004.PubMedCrossRefGoogle Scholar
  6. 6.
    Pang S, Carbunaru G, Haider A, Copeland KC, Chang YT, Lutfallah C, Mason JI. Carriers for type II 3ß-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test. Clin Endocrinol (Oxf) 58: 323, 2003.CrossRefGoogle Scholar
  7. 7.
    Draper N, Walker EA, Bujalska IK, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I. Mutations in the genes encoding 11ß-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34: 434, 2003.PubMedCrossRefGoogle Scholar
  8. 8.
    Bose HS, Sugawara T, Strauss JF, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 335: 1870, 2005.CrossRefGoogle Scholar
  9. 9.
    Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J. Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am J Med Genet 82: 382, 1999.PubMedCrossRefGoogle Scholar
  10. 10.
    Desai PK, Astrin KH, Thung SN, Gordon RE, Short MP, Coates PM, Desnick RJ. Cholesteryl ester storage disease: pathologic changes in an affected fetus. Am J Med Genet 26: 689, 1987.PubMedCrossRefGoogle Scholar
  11. 11.
    North K, Korson MS, Krawiecki N, Shoffner JM, Holm I. Oxidative phosphorylation defect associated with primary adrenal insufficiency. J Pediatr 128: 688, 1996.PubMedCrossRefGoogle Scholar
  12. 12.
    Ozisik G, Achermann JC, Jameson JL. The role of SF1 in adrenal in reproductive function: insight from naturally occurring mutations in humans. Mol Gen Metab 76: 85, 2002.CrossRefGoogle Scholar
  13. 13.
    Muscatelli F, Strom T, Walker AP, Zanaria E, Récan D, Melndl A, Bardoni B, Guioll S, Zehetner G, Rabl W. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372: 672, 1994.PubMedCrossRefGoogle Scholar
  14. 14.
    Vilain E, Le Merrer M, Lecointre C, Dsangles F, Kay MA, Maroteaux P, McCabe ERB. IMA Ge, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab 84: 4335, 1999.PubMedCrossRefGoogle Scholar
  15. 15.
    Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison’s disease in young adult male patients. J Clin Endocrinol Metab 81: 470, 2005.Google Scholar
  16. 16.
    Govaerts L, Monnens L, Melis T, Trijbels F. Disturbed adrenocortical function in cerebro-hepato-renal syndrome of Zellweger. Eur J Pediatr 143: 10, 1984.PubMedCrossRefGoogle Scholar
  17. 17.
    Huebner A, Elias LLK, Clark AJL. ACTH resistance syndrome. J Pediatr Endocrinol Metab 12: 277, 1999.PubMedGoogle Scholar
  18. 18.
    Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 26: 332, 2000.PubMedCrossRefGoogle Scholar
  19. 19.
    Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23: 327, 2002.PubMedCrossRefGoogle Scholar
  20. 20.
    Fragoso MCBV, Domenice S, Latronico AC, Martin RM, Pereira MAA, Zerbini MCN, Lucon AM, Mendonça BB. Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of the GNAS1 gene. J Clin Endocrinol Metab 88: 2147, 2003.PubMedCrossRefGoogle Scholar
  21. 21.
    Marchesa P, Fazio V, Church JM, McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40: 1023, 1997.PubMedCrossRefGoogle Scholar
  22. 22.
    Cavagnini F, Pecori Giraldi F. Adrenal causes of hypercortisolism. In: DeGroot LJ, Jameson JL (Eds). Endocrinology, Elsevier, Philadelphia, 2005.Google Scholar
  23. 23.
    Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26: 89, 2000.PubMedCrossRefGoogle Scholar
  24. 24.
    Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction. J Clin Endocrinol Metab 83: 2573, 1998.PubMedCrossRefGoogle Scholar
  25. 25.
    Geller DS. Mineralocorticoid resistance. Clin Endocrinol (Oxf) 62: 513, 2005.CrossRefGoogle Scholar
  26. 26.
    Scheinmann SJ, Guay-Woodford LM, Thakker RV, Warnock DG. Genetic disorders of renal electrolyte transport. N Engl J Med 340: 1177, 1999.CrossRefGoogle Scholar
  27. 27.
    Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metab 48: 687, 2004.CrossRefGoogle Scholar
  28. 28.
    Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658, 2001.PubMedCrossRefGoogle Scholar
  29. 29.
    Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459, 2002.PubMedCrossRefGoogle Scholar
  30. 30.
    Hes FJ, Hõppener JWM, Lips CJM. Pheochromocytoma in von Hippel-Lindau disease. J Clin Endocrinol Metab 88: 969, 2003.PubMedCrossRefGoogle Scholar
  31. 31.
    Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen’s disease and pheochro-mocytomas. J Urol 162: 1582, 1999.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2006

Authors and Affiliations

  • Francesca Pecori Giraldi
    • 1
  1. 1.Cattedra di EndocrinologiaUniversità di Milano, Ospedale San Luca, Istituto Auxologico Italiano IRCCSMilanoItalia

Personalised recommendations